Vous êtes sur la page 1sur 8

ITDOSE INFOSYSTEMS PVT. LTD.

Lab Id. 021704100028 Reg No 163189


Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 09:14PM
Barcode No 10195842

Test Name With Methodology Result Unit Biological Ref.Interval


HAEMATOLOGY
HAEMOGLOBIN 9.6 gm/dl 11.5-16.0
Whole Blood EDTA, Cyanide free

TLC (Total Leucocyte Count) 5.54 th/cumm 4.0-10.0


Whole Blood EDTA, Flowcytometry

DIFFERENTIAL LEUCOCYTE COUNT


POLYMORPHS 49.8 % 40-75
Whole Blood EDTA, Flowcytometry

LYMPHOCYTES 34 % 20-40
Whole Blood EDTA, Flowcytometry

EOSINOPHILS 7.1 % 1-6


Whole Blood EDTA, Flowcytometry

MONOCYTES 8.6 % 2-10


Whole Blood EDTA, Flowcytometry

BASOPHILS* 0.5 % 0-1


Whole Blood EDTA, Flowcytometry

ABSOLUTE NEUTROPHIL COUNT 2,759 /cumm 1600 - 8000


Whole Blood EDTA, Flowcytometry

ABSOLUTE LYMPHOCYTE COUNT 1,884 /cumm 1392 - 3510


Whole Blood EDTA, Flowcytometry

ABSOLUTE EOSINOPHIL COUNT 393 /cumm 40-440


Whole Blood EDTA, Flowcytometry

ABSOLUTE MONOCYTE COUNT 476 /cumm 100-900


Whole Blood EDTA, Flowcytometry

ABSOLUTE BASOPHILS COUNT* 28 /cumm 0-100


Whole Blood EDTA, Flowcytometry

RBC 4.21 millions/cmm 3.8-5.8


Whole Blood EDTA, Impedance

HCT 34.4 % 35-45


Whole Blood EDTA, Calculated

MCV 81.71 fl 76-96


Whole Blood EDTA, Calculated

MCH 22.8 pg 27-33


Whole Blood EDTA, Calculated

MCHC 27.91 g/dl 30-35


Whole Blood EDTA, Calculated

PLATELET COUNT 307 thou/L 150-450


Whole Blood EDTA, Impedance

MPV 9.4 fl 7.4-10.4


Whole Blood EDTA, Calculated

RDW- CV 16.3 % 11.5-14.5


Whole Blood EDTA, Flowcytometry

Page 1 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 09:14PM
Barcode No 10195842
RDW- SD 51.2 fl 35-56
Whole Blood EDTA, Flowcytometry

PCT 0.29 % 0.10-0.28


Whole Blood EDTA, Calculated

PDW 17.7 fl 9.0-17.0


Whole Blood EDTA, Calculated

ESR [WESTERGREN] 22 mm/ 1 hr 0 -20


Modified Westergren
The tests marked with an * are not accredited by NABL.

*** End Of Report ***

Page 2 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

Lab Id. 021704100028 Reg No 163189


Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842

Test Name With Methodology Result Unit Biological Ref.Interval


BIOCHEMISTRY
BLOOD SUGAR FASTING 86 mg/dl 74-106
Plasma Fluoride, Hexokinase

KIDNEY PANEL- 2
BLOOD UREA 23.9 mg/dL 17-43
Serum, Urease, GLDH

SERUM CREATININE 0.57 mg/dL 0.5-1.1


Serum, Jaffes

URIC ACID 4.2 mg/dl 2.6-6.0


Serum, Uricase

SODIUM* 140 mEq/L 135 - 148


Serum, Ion Selective Electrode

POTASSIUM* 4.43 mmol /L 3.5-5.1


Serum, Ion Selective Electrode

CHLORIDE* 98.4 mmol /L 98 - 107


Serum, Ion Selective Electrode

CALCIUM* 8.6 mg/dl 8.6-10.3


Serum, OCPC

PHOSPHOROUS SERUM* 3.43 mg/dl 2.6-4.5


Serum, Phosphomolybdate

BUN (Blood Urea Nitrogen ) 11 mg/dl 7.9-20.1


Serum, Calculated

BUN/CREATININE RATIO 19.6 Ratio 10-20


Serum, Calculated

UREA/CREATININE RATIO* 41.93 Ratio


Serum, Calculated

LIPID PROFILE
CHOLESTEROL 187.6 mg/dl <200
Serum, CHOD-PAP Enzymatic

TRIGLYCERIDE 77.5 mg/dl <150


Serum, GPO, Colorimetric

HDL-CHOLESTEROL 51.4 mg/dl 45-65


Serum, Immuno FS Method

LDL CHOLESTEROL 120.7 mg/dl 0-155


Serum, Calculated

VLDL CHOLESTEROL 15.5 mg/dl 5 - 40


Serum, Calculated

LDL / HDL RATIO 2.35 0 - 3.55


Serum, Calculated

Page 3 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842
HDL / LDL RATIO 0.43 >0.3
Serum, Calculated

CHOL / HDL RATIO 4 0 - 4.97


Serum, Calculated

NON-HDL CHOLESTEROL 136.2 mg/dl <160


Serum, Calculated

Comment:
Lipids are a group of fats and fat-like substances that are important constituents of cells and sources of energy. The lipid profile is used as part of a
cardiac risk assessment to help determine an individual's risk of heart disease. It is recommended that healthy adults with no other risk factors for
heart disease be tested with a fasting lipid profile once every four to six years. If other risk factors are present or if previous testing revealed a high
cholesterol level in the past, more frequent testing is recommended.

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAROPTIMAL 100-129 BORDERLINE HIGH 150-199

HIGH >240 BORDERLINE 130-159 HIGH 200-499


HIGH
HIGH 160-189 VERYHIGH >500

VERYHIGH >190

*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES

Liver Panel (LFT)


TOTAL BILIRUBIN 0.35 mg/dl 0.1-1.2
Serum, DCA

CONJUGATED BILIRUBIN 0.12 mg/dl 0.0-0.3


Serum, DCA

UNCONJUGATED BILIRUBIN 0.23 mg/dl 0.2-0.7


Serum, Calculated

SGOT (AST) 33.4 U/L 0-32


Serum, Optimized UV test with IFCC

SGPT (ALT) 35.2 IU/L 0-31


Serum, Optimized UV test with IFCC

ALK.PHOSPHATASE 164 IU/L 35-104


Serum, Kinetic, IFCC

T.PROTEIN 8.39 gm/dl 6.4-8.3


Serum, Biuret

ALBUMIN 3.87 gm/dl 3.5-5.3


Serum, Bromocresol Green

GLOBULIN 4.52 gm/dl 2.5-3.8


Serum, Calculated

A/G Ratio 0.86 1.30 - 1.70


Serum, Calculated

Page 4 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842
GAMMA G.T. 54 IU/L <40
Serum, Kinetic with IFCC

SGOT/SGPT Ratio 0.95 Ratio


Serum, Calculated

Comment:

A liver panel (Liver function test) or one or more of its component tests may be used to help diagnose liver disease if a person has symptoms that indicate possible liver
dysfunction. If a person has a known condition or liver disease, testing may be performed at intervals to monitor liver status and to evaluate the effectiveness of any
treatments.

Test Method: Clinical Biochemistry

Thyroid Profile-V [FT3,FT4,TSH]


FREE TRIIODOTHYRONINE [FT3]* 3.25 pg/ml 2.0-4.4
Serum, Electro Chemi Luminescent Immuno Assay

FREE THYROXINE [FT4]* 1.24 ng/dl 0.85-1.86


Serum, Electro Chemi Luminescent Immuno Assay

TSH (ULTRASENSITIVE) 2.65 uIU/ml 0.13-6.33


Serum, Electro Chemi Luminescent Immuno Assay

COMMENT:

Hypersensitive TSH test is use to screen for and help diagnose thyroid disorders; to monitor treatment of hypothyroidism and hyperthyroidism. TSH levels are
usually increased in hypothyroidism and decreased in hyperthyroidism.
Ourreferencerangeappliesthecentral95thinterval(2.5th97.5thquantile)accordingtotheCLSI/IFCCguidelinesEP28-A3c.
A circadian variation in serum TSH in healthy subjects is well documented. TSH level is reaching peak levels between 2-4 am and at a minimum between 6-

10 pm. The variation is of the order of 50%, hence time of the day has influence on the value of TSH.
TSH levels between 5.5 and 15.0 may represent subclinical or compensated hypothyroidism or show considerable physiological & seasonal variation, suggest
clinical correlation or repeat testing with fresh sample.
TSH levels may be transiently altered because of non-thyroid illness, like severe infection, renal disease, liver disease, heart disease, severe burns, trauma,
surgery etc. Few drugs also altered the TSH values.
The combination of Free T3, Free T4 and third generation TSH offer a powerful tool for the efficient and differential diagnosis and management of thyroid disorders. Free T3 and Free
T4 estimation are unaffected by changes in Thyroid Binding Globulins (TBG). A decrease in serum Free T3 and Free T4 and increase in TSH confirms the diagnosis of
Hypothyroidism. Diagnosis of Hyperthyroidism can reliable be made in patients with low TSH and elevated Free T3 and Free T4 levels.

Age Free T3 (pg/ml) Free T4 ( ng/dl) TSH(lU/ml)


1 - 6 days 1.73 - 6.30 0.86 - 2.49 0.7 - 15.0
6 days -3 months 1.95 - 6.04 0.89 - 2.20 0.72 - 11.0
4 - 12 months 2.15 - 5.83 0.92 - 1.99 0.73 - 8.35
1 - 6 years 2.41 - 5.50 0.96 - 1.77 0.70 - 5.97
7 - 11 years 2.53 - 5.22 0.97 - 1.67 0.60 - 5.84
12 - 20 years 2.56 - 5.01 0.98 - 1.63 0.51 - 6.50

Page 5 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842
>20 years 2.0 - 4.4 0.85 - 1.86 0.27 - 6.33

Method : Fully Automated Bidirectionally Interfaced Electro Chemi Luminescent Immuno Assay

Kindly correlate with clinical conditions.


The tests marked with an * are not accredited by NABL.

*** End Of Report ***

Page 6 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

Lab Id. 021704100028 Reg No 163189


Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 03:05PM
Barcode No 10195842

Test Name With Methodology Result Unit Biological Ref.Interval


CLINICAL PATHOLOGY
Urine R/M (Urine Analysis)
PHYSICAL & CHEMICAL EXAMINATION
COLOUR PALE YELLOW PALE YELLOW
TRANSPARENCY* CLEAR CLEAR
pH 6.0 4.7-7.5
Urine, Double indicator

SP.GRAVITY 1.015 1.005-1.035


Urine, Hydrogenous ionogen reaction

URINE SUGAR NOT DETECTED NOT DETECTED


Urine, Oxidation reaction

URINE PROTEIN NOT DETECTED NOT DETECTED


Urine, Protein ionization

URINE BILIRUBIN NOT DETECTED NOT DETECTED


Urine, Azo- coupling reaction

KETONES NOT DETECTED NOT DETECTED


Urine, Acetoacetate and nitroprusside reaction

UROBILINOGEN NORMAL NORMAL


Urine, p-aminobenzoic acid and phenazopyridine reaction

NITRATE* NOT DETECTED NOT DETECTED


Urine, Diazotized reaction

MICROSCOPIC EXAMINATION
PUS CELLS. 1-2 /HPF 3-5
Urine, Microscopy

EPITHELIAL CELLS 2-3 /HPF 3-5


Urine, Microscopy

R.B.C. NOT SEEN /HPF NOT SEEN


Urine, Microscopy

CRYSTALS* NOT SEEN NOT SEEN


Urine, Microscopy

CASTS* NOT SEEN /LPF NOT SEEN


Urine, Microscopy

BACTERIA NOT SEEN NOT SEEN


Urine, Microscopy

.
The tests marked with an * are not accredited by NABL.

*** End Of Report ***

Page 7 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

Lab Id. 021704100028 Reg No 163189


Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842

Test Name With Methodology Result Unit Biological Ref.Interval


BIOCHEMISTRY
Vitamin D (25-hydroxycholecalciferol)
VITAMIN D, 25 HYDROXY* 27.23 ng/mL 30-70
Reference Range :
DEFICIENCY : <20 ng/ml
INSUFFICIENCY : 20-30 ng/ml
NORMAL : 30-70 ng/ml

Comments:

This test is used to determine the levels of 25-hydroxy-vitamin D and is used to determine if bone weakness, bone malformation, or abnormal metabolism of calcium is
occurring as a result of a deficiency or excess of vitamin D. Since vitamin D is a fat-soluble vitamin and is absorbed from the intestine like a fat, vitamin D is also s used
to monitor individuals with diseases that interfere with fat absorption, such as cystic fibrosis and Crohn's disease, and in patients who have had gastric bypass surgery and
may not be able to absorb enough Vitamin D. Vitamin D is also used to determine effectiveness of treatment when vitamin D, calcium, phosphorus, and/or magnesium
supplementation is prescribed. Reasons for suboptimal 25-OH-VitD levels include lack of sunshine exposure, inadequate intake; malabsorption eg, due to Celiac disease);
depressed hepatic vitamin D 25-hydroxylase activity, secondary to advanced liver disease; and enzyme-inducing drugs, in particular many antiepileptic drugs, including
phenytoin, phenobarbital, and carbamazepine, that increase 25-OH-VitD metabolism. In contrast to the high prevalence of 25-OH-VitD deficiency, hypervitaminosis D
is rare, and is only seen after prolonged exposure to extremely high doses of vitamin D. When it occurs, it can result in severe hypercalcemia and hyperphosphatemia.

Method : Fully Automated Bidirectionally Interfaced Electro Chemi Luminescent Immuno Assay

Kindly correlate with clinical conditions.


The tests marked with an * are not accredited by NABL.

*** End Of Report ***

Page 8 of 8

Vous aimerez peut-être aussi